COVID-19’s Impact on the Supply Chain in Asia-Pacific
COVID-19, Supply Chain
Our latest webinar, held on February 25, 2022, focused on COVID-19’s impact on the clinical trial supply chain in the Asia-Pacific region. The session aimed to provide a clearer picture of the pandemic’s impact, and help equip attendees to build a resilient supply chain in similarly challenging situations.
Two clinical supply professionals shared their insights on how the pandemic affected clinical supply, including the resulting solutions and a sponsor company’s perspective on the specific challenges impacting China. The expert speakers were:
- Tessa Lai, Clinical Supply Operation Asia lead, Bristol Myers Squibb
- Mervin Sulistyo, Value Engineering Service, AmerisourceBergen World Courier
The presentation and recording from the webinar are available here:
Click here for more information about the Asia-Pacific Clinical Supplies Webinar Series
Related Education Resources.
All ResourcesGCSG sponsored study on Patient Receptivity to Direct-to-Patient Shipment in Clinical Trials
Topic: Direct-to-Patient
White Paper
Members
Envisioning the Future of Clinical Supply Chains in the Next 10 Years
Topic: Supply Chain
Executive Summary
Members
Demand Forecasting and the Management of IRT
Topic: Technology
Webinar
Free
